Heparin-coated circuit in coronary surgery: A clinical study

European Journal of Cardio-thoracic Surgery

Volumn 10, Issue 1, 1996, Pages 48-53

  Saenz A ^a   Larranaga G ^a   Alvarez, L ^a   Greco, E ^a   Marrero, A ^a   Lunar, M ^a   Elosegui C ^a   Ubago, J L ^a   Gallo, I ^a  

^a Cardiovascular Unit   (Spain)

Author keywords

Anticoagulation; Cardiopulmonary bypass; Extracorporeal circulation; Heparin; Heparin surface coating

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

AGED; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HUMAN; METHODOLOGY; MIDDLE AGED; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; HEPARIN; HUMANS; INTRAOPERATIVE COMPLICATIONS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0029685657     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)80265-X     Document Type: Article

References (34)

1. Baier RE, Dutton RC (1969) Initial events in interactions of blood with a foreing surface. J Biomed Mater Res 142:1297-1298
2. Belboul A, Al-Khaja N, Gudmundsson M, Karlsson H, Uchino T, Liu B, El-Gatit A, Bjell A, Roberts D, William-Olsson G (1993) The influence of heparin-coated and uncoated extracorporeal circuits on blood rheology during cardiac surgery. J Extra-Corpor Tech 25:40-46
3. Bey R, Mottaghy K, Oedekoven B, Schmid-Schonbein H (1982) Reduction of heparin in extracorporeal circulations (ECC) in small animals applying different prostacyclins. Proc Eur Soc Artif Organs 9:153-156
4. Bonnstra PW, Gu YJ, Akkerman C, Haan J, Huyzen R, Van Oeveren W (1994) Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 107:289-292
5. Borowiec J, Thelin S, Bagge L, Hultman J, Hansson H (1992) Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose. Scand J Thorac Cardiovasc Surg 26:177-185
6. Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson HE (1992) Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg 104:642-647
7. Borowiecz JW, Bylock A, Van der Linden J, Thelin S (1993) Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: A clinical study. Ann Thorac Surg 55:1540-1545
8. Campanella C, Cameron E, Sinclair C, Feilberg VL, Hider C, Prasad S, Boulton F, Lamb D (1991) Preliminary results of left heart bypass in pigs using a heparin-coated centrifugal pump. Ann Thorac Surg 52:245-249
9. Cines CB (1986) Heparin Do we understand its antithrombotic action? Chest 89:426-429
10. Dowling RD, Brown ME, Whittington RO, Quinlan JJ, Armitage JM (1993) Clinical cardiopulmonary bypass without systemic anticoagulation. Ann Thorac Surg 56:1176-1178
11. Gott VL, Whiffen JD, Dutton RC (1963) Heparin bonding on colloidal graphite surfaces Science 142:1297-1299
12. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins A, Nicoloff DM, Lillehei RC, Craddock PR, Jacob HS (1981) Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 81:370-377
13. Jones DR, Hill RC, Hollingsed MJ, Stullken E, Graeber GM, Gustafson RA, Murray GF (1993) Use of heparin-coated cardiopulmonary bypass. Ann Thorac Surg 56:566-568
14. Jones DR, Hill RC, Vasilakis A, Hollingsed MJ, Graeber GM, Gustafson RA, Cruzzavala JL, Murray GF (1994) Safe use of heparin-coated bypass circuits incorporating a pump-oxygenator. Ann Thorac Surg 57:815-819
15. Kirklin JK, Westaby S, Blackstone EU, Kirklin JW, Chenoweth DE, Pacifico AD (1983) Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86: 845-857
16. Kirklin JK, Chenoweth DE, Naftel DC, Blackstone EH, Kirklin JW, Bitran DD, Curd JJ, Reves JG, Samuelson PN (1986) Effects of protamine administration after cardiopulmonary bypass on complement, blood elements and the hemodynamic state. Ann Thorac Surg 41:193-199
17. Kirklin JK, The postperfusion syndrome: inflammation and the damaging effects of cardiopulmonary bypass. In: Tinker JH (ed) Cardiopulmonary bypass: current concepts and controversies Saunders, Philadelphia, 1989:131
18. Klein MD, Arensman RM, Weber TR, Mottaghy K, Langer R, Nolte NH (1988) Pediatric ECMO: directions for new developments ASAIO Trans 34:978-985
19. Larm O, Larsson R, Olsson P (1983) A new non-thrombogenic surface produced by selective covalent binding of heparin via a modified reduced terminal residue. Biomat Med Dev Artif Organs 11:161-163
20. Moat NE, Shore DF, Evans TW (1993) Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 7:563-573
21. Mottaghy K, Oedekoven B, Pöppel K, Bruchmüller K, Kovacs B, Spahn A, Geisen C (1989) Heparin free long-term extracorporeal circulation using bioactive surfaces ASAIO Trans 35:635-637
22. Nilsson L, Storm KE, Thelin S, Bagge L, Hultman J, Thorelius J, Nilsson U (1989) Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig Artif Organs 14:46-48
23. Oedekoven B, Bey R, Mottaghy K, Schmid-Schönbein H (1984) Gabexate mesilate (FOYR) as an anticoagulant in extracorporeal circulation in dogs and sheep. Thromb Haemost 52:229-232
24. Redmond JM, Gillinov AM, Stuart RS, Zehr KJ, Winkelstein JA, Herskowitz A, Cameron DE, Baumgartner WA (1993) Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 56:474-479
25. Svennevig JL, Geiran OR, Karlsen H, Pedersen T, Mollnes TE, Kongsgard V, Froysakert T (1993) Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 106:466-472
26. Thelin S, Bagge L, Hultman J, Borowiec J, Nilsson L, Thorelius J (1991) Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. Eur J Cardiothorac Surg 5:486-491
27. Videm V, Nilsson L, Venge P, Svennevig J (1990) Reduced granulocyte activation with heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs 15:90-95
28. Videm V, Mollnes TE, Garred P, Svennevig JL (1991) Biocompatibility of extracorporeal circulation. J Thorac Cardiovasc Surg 101:654-660
29. Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE (1992) Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations J Thorac Cardiovasc Surg 103:806-813
30. Von Segesser LK, Lachat M, Gallino A, Weis BM, Leskosek B, Garcia E, Hanseler E, Von Felton A, Turina M (1990) Performance characteristics of centrifugal pumps with heparin surface coating. Thorac Cardiovasc Surg 38:224-228
31. Von Segesser LK, Weis BM, Gallino A, Leskosek B, Redha F, Von Felton A, Turina M (1990) Superior hemodynamics in left heart bypass without systemic heparinization. Eur J Cardiothorac Surg 4:384-389
32. Von Segesser LK, Weiss BM, Garcia E, Gallino A, Turina MI (1990) Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization Eur J Cardiothorac Surg 4:639-643
33. Von Segesser LK, Weiss BM, Garcia E, Von Felton A, Turina MI (1992) Reduction and elimination of systemic heparinization during cardiopulmonary bypass. J Thorac Cardiovasc Surg 103:790-799
34. Woodman RC, Harker LA (1990) Bleeding complications associated with cardiopulmonary bypass Blood 9:1680-1697